JAMP KETOTIFEN DIN 02489651
Health Canada record
| Active ingredient(s) | KETOTIFEN (KETOTIFEN FUMARATE) 0.025 % W/V |
|---|---|
| Dosage form | Solution |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01GX08 KETOTIFEN |
| Original market date | |
| Current status date | 27-Mar-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35083 | 2025-03-27 | Supplement to an Abbreviated New Drug Submission (SANDS) | Change in product name. Update to Product Monograph (to align with CRP approved PM) |
| 22330 | 2019-06-27 | Abbreviated New Drug Submission (ANDS) |